not to to get ahead of ourselves but in my mind todays circa 100m market cap should be closer to 200-400m if we didn't have such a habit of over promising on deals and if we had more cash. ie todays price isn't the right starting point for valuation.
I think fda approval and a deal will mean we re rate and I agree paro hopefully funds. deals plural mean I hope we sit around the 2 buck range for a while and even pre revenue as we progress to the end of the trial I don't think It is impossible we are 3-4-5 bucks. to your point PE in year 1-3 isn't so relevant, it's about is the drug getting sales traction and is it potentially a blockbuster.
at this point it's just a dream. I'm focused as I believe PAR is on fda / funding. let's cross that bridge first !
- Forums
- ASX - By Stock
- PAR
- Sharewise Presentation 22/7/24
Sharewise Presentation 22/7/24, page-67
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
26.5¢ |
Change
-0.020(7.02%) |
Mkt cap ! $92.69M |
Open | High | Low | Value | Volume |
29.0¢ | 29.0¢ | 26.0¢ | $229.3K | 833.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 89111 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.0¢ | 25136 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 89111 | 0.260 |
3 | 53215 | 0.255 |
5 | 133500 | 0.250 |
5 | 72763 | 0.245 |
6 | 87200 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.270 | 25136 | 1 |
0.285 | 10000 | 1 |
0.290 | 14580 | 3 |
0.300 | 18807 | 4 |
0.305 | 50000 | 1 |
Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |